日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Combinatorial therapy regimens targeting preclinical models of melanoma resistant to immune checkpoint blockade

针对免疫检查点阻断耐药黑色素瘤临床前模型的联合治疗方案

Imran Khan ,Aida Rodriguez-Brotons ,Anukana Bhattacharjee ,Vladimir Bezrookove ,Altaf Dar ,David De Semir ,Mehdi Nosrati ,Ryan Ice ,Liliana Soroceanu ,Stanley P Leong ,Kevin B Kim ,Yihui Shi ,James E Cleaver ,James R Miller 3rd ,Pierre-Yves Desprez ,John M Kirkwood ,Marcus Bosenberg ,Nathan Salomonis ,Sean McAllister ,Mohammed Kashani-Sabet

miR-876-3p is a tumor suppressor on 9p21 that is inactivated in melanoma and targets ERK

miR-876-3p 是 9p21 上的一种肿瘤抑制因子,在黑色素瘤中失活,并以 ERK 为目标

Vladimir Bezrookove #, Imran Khan #, Anukana Bhattacharjee, Juifang Fan, Robyn Jones, Anima Sharma, Mehdi Nosrati, Pierre-Yves Desprez, Nathan Salomonis, Yihui Shi, Altaf Dar, Mohammed Kashani-Sabet